Layla D. Berry

Array ( [id] => 12016924 [patent_doc_number] => 09809617 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-11-07 [patent_title] => 'Crystal form of regadenoson and preparation method thereof' [patent_app_type] => utility [patent_app_number] => 14/791290 [patent_app_country] => US [patent_app_date] => 2015-07-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 8 [patent_no_of_words] => 3313 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14791290 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13182141 [patent_doc_number] => 10106572 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2018-10-23 [patent_title] => Supramolecular hacky sacks (SHS), method of synthesis and applications thereof [patent_app_type] => utility [patent_app_number] => 14/791360 [patent_app_country] => US [patent_app_date] => 2015-07-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 36 [patent_no_of_words] => 10559 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14791360 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10430217 [patent_doc_number] => 20150315228 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-11-05 [patent_title] => 'SUBSTITUTED NUCLEOSIDES, NUCLEOTIDES AND ANALOGS THEREOF' [patent_app_type] => utility [patent_app_number] => 14/790645 [patent_app_country] => US [patent_app_date] => 2015-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 92598 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14790645 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10430217 [patent_doc_number] => 20150315228 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-11-05 [patent_title] => 'SUBSTITUTED NUCLEOSIDES, NUCLEOTIDES AND ANALOGS THEREOF' [patent_app_type] => utility [patent_app_number] => 14/790645 [patent_app_country] => US [patent_app_date] => 2015-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 92598 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14790645 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10430217 [patent_doc_number] => 20150315228 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-11-05 [patent_title] => 'SUBSTITUTED NUCLEOSIDES, NUCLEOTIDES AND ANALOGS THEREOF' [patent_app_type] => utility [patent_app_number] => 14/790645 [patent_app_country] => US [patent_app_date] => 2015-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 92598 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14790645 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10430217 [patent_doc_number] => 20150315228 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-11-05 [patent_title] => 'SUBSTITUTED NUCLEOSIDES, NUCLEOTIDES AND ANALOGS THEREOF' [patent_app_type] => utility [patent_app_number] => 14/790645 [patent_app_country] => US [patent_app_date] => 2015-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 92598 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14790645 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12058676 [patent_doc_number] => 20170335021 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-11-23 [patent_title] => 'BIOCOMPATIBLE COMPOSITION AND METHOD FOR PREPARING SAME' [patent_app_type] => utility [patent_app_number] => 15/531837 [patent_app_country] => US [patent_app_date] => 2015-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 2828 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15531837 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10799136 [patent_doc_number] => 20160145293 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-05-26 [patent_title] => 'OLIGONUCLEOTIDES CONTAINING HIGH CONCENTRATIONS OF GUANINE MONOMERS' [patent_app_type] => utility [patent_app_number] => 14/748045 [patent_app_country] => US [patent_app_date] => 2015-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9433 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14748045 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11809063 [patent_doc_number] => 09713622 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-07-25 [patent_title] => 'Schedules for administering combination therapies useful for treating persons afflicted with the human immunodeficiency virus (HIV)' [patent_app_type] => utility [patent_app_number] => 14/747621 [patent_app_country] => US [patent_app_date] => 2015-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 12239 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 130 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14747621 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13127461 [patent_doc_number] => 10081651 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-09-25 [patent_title] => Chlorination of sucrose-6-esters [patent_app_type] => utility [patent_app_number] => 15/502372 [patent_app_country] => US [patent_app_date] => 2015-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 10159 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 121 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15502372 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11596839 [patent_doc_number] => 09643991 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-05-09 [patent_title] => 'Process for preparing a novel crystalline form of emamectin benzoate and use the same' [patent_app_type] => utility [patent_app_number] => 14/733054 [patent_app_country] => US [patent_app_date] => 2015-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5231 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14733054 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11604059 [patent_doc_number] => 20170121360 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-05-04 [patent_title] => 'APPARATUS AND METHOD FOR OBTAINING GLYCOGLYCEROLIPIDS AND GLYCOSPHINGOLIPIDS FROM LIPID PHASES' [patent_app_type] => utility [patent_app_number] => 15/316123 [patent_app_country] => US [patent_app_date] => 2015-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 29196 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15316123 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13814501 [patent_doc_number] => 10184011 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-01-22 [patent_title] => Hemostatic devices with improved properties and methods of making same [patent_app_type] => utility [patent_app_number] => 14/719701 [patent_app_country] => US [patent_app_date] => 2015-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4493 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 190 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14719701 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12009586 [patent_doc_number] => 09802890 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-10-31 [patent_title] => 'Processes for the convergent synthesis of calicheamicin derivatives' [patent_app_type] => utility [patent_app_number] => 14/711267 [patent_app_country] => US [patent_app_date] => 2015-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7662 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14711267 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13116403 [patent_doc_number] => 10076537 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-09-18 [patent_title] => Glycosaminoglycan composition and method of use for kidney stone removal [patent_app_type] => utility [patent_app_number] => 15/307465 [patent_app_country] => US [patent_app_date] => 2015-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6379 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15307465 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11936505 [patent_doc_number] => 20170240655 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-08-24 [patent_title] => 'METHOD FOR PRODUCING SIALIC-ACID-CONTAINING SUGAR CHAIN' [patent_app_type] => utility [patent_app_number] => 14/702535 [patent_app_country] => US [patent_app_date] => 2015-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 12466 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14702535 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13127463 [patent_doc_number] => 10081652 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-09-25 [patent_title] => Purification of epidaunorubicin [patent_app_type] => utility [patent_app_number] => 15/307488 [patent_app_country] => US [patent_app_date] => 2015-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4036 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15307488 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11663816 [patent_doc_number] => 20170152536 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-06-01 [patent_title] => 'METHOD FOR TRANSFORMING LEVOGLUCOSENONE INTO 4-HYDROXYMETHYN BUTYROLACTONE OR 4-HYDROXYMETHYL BUTENOLIDE' [patent_app_type] => utility [patent_app_number] => 15/307712 [patent_app_country] => US [patent_app_date] => 2015-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 8314 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15307712 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10340435 [patent_doc_number] => 20150225440 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-08-13 [patent_title] => 'MANUFACTURING METHOD FOR POLYPHENOL COMPOSITION' [patent_app_type] => utility [patent_app_number] => 14/694317 [patent_app_country] => US [patent_app_date] => 2015-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12790 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14694317 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10333657 [patent_doc_number] => 20150218661 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-08-06 [patent_title] => 'METHOD USING GLYCAN IMMOBILIZED METAL NANOPARTICLES FOR EARLY HIV-1 DETECTION' [patent_app_type] => utility [patent_app_number] => 14/694509 [patent_app_country] => US [patent_app_date] => 2015-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 4931 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14694509 [rel_patent_id] =>[rel_patent_doc_number] =>)